Age- and region-dependent alterations in Aβ-degrading enzymes:: implications for Aβ-induced disorders

被引:259
作者
Caccamo, A [1 ]
Oddo, S [1 ]
Sugarman, MC [1 ]
Akbari, Y [1 ]
LaFerla, FA [1 ]
机构
[1] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA
关键词
amyloid beta-protein; insulin-degrading enzyme; neprilysin; A beta; AD; IDE; IBM;
D O I
10.1016/j.neurobiolaging.2004.06.013
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Accumulation of amyloid beta-protein (Abeta) is a fundamental feature of certain human brain disorders such as Alzheimer's disease (AD) and Down syndrome and also of the skeletal muscle disorder inclusion body myositis (IBM). Emerging evidence suggests that the steady-state levels of Abeta are determined by the balance between production and degradation. Although the proteolytic processes leading to Abeta formation have been extensively studied, less is known about the proteases that degrade Abeta, which include insulin-degrading enzyme (IDE) and neprilysin (NEP). Here we measured the steady-state levels of these proteases as a function of age and brain/muscle region in mice and humans. In the hippocampus, which is vulnerable to AD pathology, IDE and NEP steady-state levels diminish as function of age. By contrast, in the cerebellum, a brain region not marked by significant Abeta accumulation, NEP and IDE levels either increase or remain unaltered during aging. Moreover, the steady-state levels of IDE and NEP are significantly higher in the cerebellum compared to the cortex and hippocampus. We further show that IDE is more oxidized in the hippocampus compared to the cerebellum of AD patients. In muscle, we find differential levels of IDE and NEP in fast versus slow twitch muscle fibers that varies with aging. These findings suggest that age- and region-specific changes in the proteolytic clearance of Abeta represent a critical pathogenic mechanism that may account for the susceptibility of particular brain or muscle regions in AD and IBM. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:645 / 654
页数:10
相关论文
共 37 条
[1]   BETA-AMYLOID PROTEIN IMMUNOREACTIVITY IN MUSCLE OF PATIENTS WITH INCLUSION-BODY MYOSITIS [J].
ASKANAS, V ;
ENGEL, WK ;
ALVAREZ, RB ;
GLENNER, GG .
LANCET, 1992, 339 (8792) :560-561
[2]   Insulin-degrading enzyme in the Alzheimer's disease brain:: prominent localization in neurons and senile plaques [J].
Bernstein, HG ;
Ansorge, S ;
Riederer, P ;
Reiser, M ;
Frölich, L ;
Bogerts, B .
NEUROSCIENCE LETTERS, 1999, 263 (2-3) :161-164
[3]   Evidence for genetic linkage of Alzheimer's disease to chromosome 10q [J].
Bertram, L ;
Blacker, D ;
Mullin, K ;
Keeney, D ;
Jones, J ;
Basu, S ;
Yhu, S ;
McInnis, MG ;
Go, RCP ;
Vekrellis, K ;
Selkoe, DJ ;
Saunders, AJ ;
Tanzi, RE .
SCIENCE, 2000, 290 (5500) :2302-+
[4]   Declining expression of neprilysin in Alzheimer disease vasculature: Possible involvement in cerebral amyloid angiopathy [J].
Carpentier, M ;
Robitaille, Y ;
DesGroseillers, L ;
Boileau, G ;
Marcinkiewicz, M .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (10) :849-856
[5]   Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-ε4 allele [J].
Cook, DG ;
Leverenz, JB ;
McMillan, PJ ;
Kulstad, JJ ;
Ericksen, S ;
Roth, RA ;
Schellenberg, GD ;
Jin, LW ;
Kovacina, KS ;
Craft, S .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (01) :313-319
[6]   Degradation of the Alzheimer's amyloid β peptide by endothelin-converting enzyme [J].
Eckman, EA ;
Reed, DK ;
Eckman, CB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (27) :24540-24548
[7]   Insulin-degrading enzyme rapidly removes the β-amyloid precursor protein intracellular domain (AICD) [J].
Edbauer, D ;
Willem, M ;
Lammich, S ;
Steiner, H ;
Haass, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) :13389-13393
[8]   Linkage of plasma Aβ42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees [J].
Ertekin-Taner, N ;
Graff-Radford, N ;
Younkin, LH ;
Eckman, C ;
Baker, M ;
Adamson, J ;
Ronald, J ;
Blangero, J ;
Hutton, M ;
Younkin, SG .
SCIENCE, 2000, 290 (5500) :2303-+
[9]   Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo [J].
Farris, W ;
Mansourian, S ;
Chang, Y ;
Lindsley, L ;
Eckman, EA ;
Frosch, MP ;
Eckman, CB ;
Tanzi, RE ;
Selkoe, DJ ;
Guénette, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :4162-4167
[10]   Clearance of extracellular and cell-associated amyloid β peptide through viral expression of neprilysin in primary neurons [J].
Hama, E ;
Shirotani, K ;
Masumoto, H ;
Sekine-Aizawa, Y ;
Aizawa, H ;
Saido, TC .
JOURNAL OF BIOCHEMISTRY, 2001, 130 (06) :721-726